---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295131985.md"
description: "Protagonist Therapeutics shares are trading higher after Barclays raised its price target on the stock from $151 to $153."
datetime: "2026-08-06T17:41:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295131985.md)
  - [en](https://longbridge.com/en/news/295131985.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295131985.md)
generator: "portal-rs"
---

# 

Protagonist Therapeutics shares are trading higher after Barclays raised its price target on the stock from $151 to $153.

### Related Stocks

- [PTGX.US](https://longbridge.com/en/quote/PTGX.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)

## Related News & Research

- [Protagonist Therapeutics grants inducement equity awards for 7,175 shares to new hires at USD 155.1 strike price](https://longbridge.com/en/news/296264888.md)
- [Protagonist Therapeutics (PTGX) Swings To Net Income, Is The Valuation Too Expensive?](https://longbridge.com/en/news/295354544.md)
- [The Rocket Is Only 1 Piece of Rocket Lab’s Real Strategy](https://longbridge.com/en/news/296396212.md)
- [Crude Prices Fall as Oil Supplies Move Through the Strait of Hormuz](https://longbridge.com/en/news/296808052.md)
- [Van Hulzen Asset Management LLC Makes New Investment in Archer Daniels Midland Company $ADM](https://longbridge.com/en/news/296896426.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**